Beam Therapeutics Inc. (BEAM)

NasdaqGS • Currently down 0.28 (-1.13%) in today's trading session

1 member of Congress has disclosed 1 trade in Beam Therapeutics Inc. (BEAM) via STOCK Act filings. The most recent disclosure was a sale by Lois Frankel on 12 August 2013.

Beam Therapeutics Inc. is currently trading at $24.56, positioned at 24% of its 52-week range ($20.23 – $38.26).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$24.56
24h Change
-0.28 (-1.13%)
52 Week Range
$20.23–$38.26
View on NASDAQ

Beam Therapeutics Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BEAM

Select to highlight on chart
1 transactions
Compliance: 100%
Lois Frankel12 Aug 201327 Aug 2013SaleStock$1,000 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$2.54B

Volume

1.38M

Beta

2.20

P/E Ratio

-7.47

Fundamentals

EPS

$-3.29

Div. Yield

-

Open

$24.39

Day Range

$24.00 – $25.29

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
John Evans
IPO Date
2020-02-06
Website
www.beamtx.com

Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily wi...

Earnings

Next Report

Q3 2026

3 Nov

EPS Est.

$-1.15

Rev. Est.

$8.8M

Days Until

11

Recent Quarters

Q2 20264 Aug
EPS$-1.18
Miss 6.3%
Q1 20267 May
EPS$-0.91
Miss 4.6%
Q4 202524 Feb
EPS$-0.10
Beat 91.2%
Q3 20254 Nov
EPS$-1.10
Miss 12.2%
Q2 20255 Aug
EPS$-1.00
Beat 3.9%
Q1 20256 May
EPS$-1.24
Miss 11.7%
Q4 202425 Feb
EPS$-1.09
Beat 12.8%
Q3 20245 Nov
EPS$-1.17
Miss 3.5%
Q2 20246 Aug
EPS$-1.11
Beat 1.8%
Q1 20247 May
EPS$-1.21
Beat 16.6%
Q4 202327 Feb
EPS$1.73
Beat 271.3%
Q3 20238 Nov
EPS$-1.22
Beat 10.9%
Q2 20238 Aug
EPS$-1.08
Beat 21.7%
Q1 202310 May
EPS$-1.33
Beat 2.2%
Q4 202228 Feb
EPS$-0.54
Beat 59.1%
Q3 20227 Nov
EPS$-1.56
Miss 20.0%
Q2 20229 Aug
EPS$-1.02
Beat 5.6%
Q1 20229 May
EPS$-1.01
Beat 8.2%
Q4 202128 Feb
EPS$-0.85
Beat 16.7%
Q3 20218 Nov
EPS$-0.42
Beat 46.1%
Q2 202110 Aug
EPS$-0.95
Miss 63.8%
Q1 202111 May
EPS$-3.35
Miss 365.3%
Q4 202015 Mar
EPS$-0.72
Miss 2.9%
Q3 202010 Nov
EPS$-0.69
Miss 21.1%
Q2 202012 Aug
EPS$-0.69
Miss 23.2%
Q1 202012 May
EPS$-1.03
Miss 87.3%
Q4 201930 Mar
EPS$-4.47
Miss 759.6%
Q4 20197 Feb
EPS$-0.54
Q1 201930 Jun
EPS$-0.51
Q4 201831 Mar
EPS$-0.39
Q3 201831 Dec
EPS$-0.72
Q2 201830 Sept
EPS$-1.99
Q1 201830 Jun
EPS$-8.11
Q4 201731 Mar
EPS$-8.11

Dividends

Dividend History

4 Nov 2013
Amount $0.2250
12 Aug 2013
Amount $0.2250
6 May 2013
Amount $0.2250
4 Feb 2013
Amount $0.2250
6 Feb 2012
Amount $0.2100

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BEAM

Which members of Congress have traded BEAM?
1 member of Congress has disclosed 1 trade in Beam Therapeutics Inc. (BEAM) under the STOCK Act: Lois Frankel.
When was BEAM most recently disclosed by Congress?
The most recent BEAM disclosure was a sale by Lois Frankel on 12 August 2013.
How can I track new congressional trades in BEAM?
This BEAM page updates as soon as new STOCK Act disclosures are filed for Beam Therapeutics Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.